Combination of adeno-associated virus and adenovirus vectors expressing bone morphogenetic protein-2 produces enhanced osteogenic activity in immunocompetent rats

Biochemical and Biophysical Research Communications

Volumn 317, Issue 3, 2004, Pages 675-681

  Chen, Yan ^a,b   Luk, Keith D K ^b   Cheung, Kenneth M C ^b   Lu, William W ^b   An, Xiao Meng ^b,c   Ng, Samuel S M ^c   Lin, Marie C ^c,d   Kung, Hsiang Fu ^c,d  

^a QINGDAO UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adeno associated virus; Adenovirus; Bone; Bone morphogenetic protein 2; Gene therapy

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE RADIOGRAPHY; CONTROLLED STUDY; EMBRYO; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOHISTOLOGY; MALE; NEWBORN; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DEPENDOVIRUS; GENETIC VECTORS; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MALE; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE;

EID: 1842740302     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.098     Document Type: Article

References (23)

1. Wozney J.M., Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin. Orthop. 346:1998;26-37.
2. Chen Y. Orthopaedic applications of gene therapy. J. Orthop. Sci. 6:2001;199-207.
3. Fang J J., Zhu Y.Y., Smiley E., Bonadio J., Rouleau J.P., Goldstein S.A., McCauley L.K., Davidson B.L., Roessler B.J. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. 93:1996;5753-5758.
4. Bonadio J., Smiley E., Patil P., Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5:1999;753-759.
5. Alden T.D., Pittman D.D., Hankins G.R., Beres E.J., Engh J.A., Das S., Hudson S.B., Kerns K.M., Kallmes D.F., Helm G.A. In vivo endochondral bone formation using a bone morphogenetic protein-2 adenoviral vector. Hum. Gene Ther. 10:1999;2245-2253.
6. Lieberman J.R., Daluiski A., Stevenson S., Wu L., McAllister P., Lee Y.P., Kabo J.M., Finerman G.A., Berk A.J., Witte O.N. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. Am. 81:1999;905-917.
7. Chen Y., Cheung K.M., Kung H.F., Leong J.C., Lu W.W., Luk K.D. In vivo new bone formation by direct transfer of adenoviral mediated bone morphogenetic protein-4 gene. Biochem. Biophys. Res. Commun. 298:2002;121-127.
8. Breitbart A.S., Grande D.A., Mason J.M., Barcia M., James T., Grant R.T. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann. Plast. Surg. 42:1999;488-495.
9. Peng H H., Chen S.T., Wergedal J.E., Polo J.M., Yee J.K., Lau K.H., Baylink D.J. Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4. Mol. Ther. 4:2001;95-104.
10. Chen Y., Luk K.D., Cheung K.M., Xu R., Lin M.C., Lu W.W., Leong J.C., Kung H.F. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Ther. 10:2003;1345-1353.
11. Luk K.D., Chen Y., Cheung K.M., Kung H.F., Lu W.W., Leong J.C. Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation. Biochem. Biophys. Res. Commun. 308:2003;636-645.
12. Monahan P.E., Samulski R.J. Adeno-associated virus vectors for gene therapy: more pros than cons? Mol. Med. Today. 6:2002;433-440.
13. Flotte T.R., Carter B.J. Adeno-associated virus vectors for gene therapy. Gene Ther. 2:1995;357-362.
14. Xiao X., Li J., Samulski R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:1996;8098-8108.
15. Rabinowitz J.E., Samulski J. Adeno-associated virus expression systems for gene transfer. Curr. Opin. Biotechnol. 9:1998;470-475.
16. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:1992;97-129.
17. Samulski R.J., Chang L.S., Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:1989;3822-3828.
18. Qiao C., Li J., Skold A., Zhang X., Xiao X. Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes. J. Virol. 76:1996;1904-1913.
19. Ferrari F.K., Samulski T., Shenk T., Samulski R.J. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:1996;3227-3234.
20. Fisher K.J., Gao G.P., Weitzman M.D., DeMatteo R., Burda J.F., Wilson J.M. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:1996;520-532.
21. Yakobson B., Koch T., Winocour E. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J. Virol. 61:1987;972-981.
22. Yakobson B., Hrynko T.A., Peak M.J., Winocour E. Replication of adeno-associated virus in cells irradiated with UV light at 254. nm J. Virol. 63:1989;1023-1030.
23. Okubo Y., Bessho K., Fujimura K., Iizuka T., Miyatake S.I. Osteoinduction by bone morphogenetic protein 2 via adenoviral vector under transient immunosuppression. Biochem. Biophys. Res. Commun. 267:2000;382-387.